1. Adams, R. D. and Foley J. M. (1953) The neurological disorder associated with liver disease, inMetabolic and Toxic Diseases of the Nervous System (Merritt H. H. and Hare C. C., eds), vol. 32, pp. 198–237, Williams and Wilkins, Baltimore, MD.
2. Butterworth R. F. and Giguère J. F. (1984) Region-selective glutamine changes in the CNS in relation to function in experimental subacute hepatic encephalopathy, inAdvances in Hepatic Encephalopathy and Urea Cycle Diseases (Kleinberger G., Ferenci P., Riederer P., and Thaler H., eds.), Karger, Basel, Switzerland, pp. 394–401.
3. Butterworth R. F. and Giguère J. F. (1986) Cerebral amino acids in Portal-Systemic Encephalopathy: Lack of evidence for altered γ-aminobutyric acid (GABA) function.Metab. Brain Dis. 1, 221–228.
4. Butterworth R. F., Giguère J. F., Samii A., and Bergeron M. (1986) Regional glutamate changes in experimental hepatic encephalopathy.Trans. Am. Soc. Neurochem. 17, 242.
5. Eck N. V. (1877) Ligature of the portal vein.Voen. Med. J. St. Petersburg. (Russ.) 130, 1–2. See translation by C. G. Child,Surgery, Gynecology and Obstetrics, 375–376 (1953).